Ligand Pharmaceuticals (LGND) shares outstanding

Shares outstanding · fiscal 2025
20.29M

Ligand Pharmaceuticals (LGND) had 20.29M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 11.0% higher than the 18.29M of fiscal 2024. Figures as of 18 Nov 2026, 12:20 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
20.29M
Change on fiscal 2024
+11.0%
Growth, 5 years
+3.8% a year
Growth, 10 years
−5.0% a year
Highest on record
38.58Mfiscal 2018
Lowest on record
16.83Mfiscal 2020
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Ligand Pharmaceuticals shares outstanding, in more detail

The market data feed counts 20.00M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 3.8% a year; over ten years the rate was −5.0% a year. Across the 17 fiscal years on record (2009–2025), the highest was 38.58M in fiscal 2018 and the lowest 16.83M in fiscal 2020.

History · 17 fiscal years

Shares outstanding by fiscal year

Ligand Pharmaceuticals shares outstanding, year by year

Ligand Pharmaceuticals (LGND) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202520.29M 11.0% up
202418.29M 3.0% up
202317.76M 5.3% up
202216.87M 2.2% down
202117.25M 2.5% up
202016.83M 46.9% down
201931.67M 17.9% down
201838.58M 2.5% up
201737.64M 12.7% up
201633.39M 1.9% down
201534.03M 1.0% down
201434.36M 3.3% up
201333.25M 4.5% up
201231.82M 0.7% up
201131.60M 0.5% up
201031.44M 4.0% up
200930.24M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Ligand Pharmaceuticals and comparable companies
CompanyShares outstandingFiscal year
RadNet RDNT75.19M2025
Belite Bio BLTE33.54M2025
Ligand Pharmaceuticals LGND20.29M2025
Scholar Rock Holding SRRK114.70M2025
Teleflex TFX44.72M2025
Mirum Pharmaceuticals MIRM50.20M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on LGND

Ligand Pharmaceuticals, figure by figure

Ligand Pharmaceuticals (LGND) overview: price, valuation and scorecardAll health care companies by market value

Ligand Pharmaceuticals shares outstanding: questions and answers

How many shares does Ligand Pharmaceuticals have?

Ligand Pharmaceuticals (LGND) had 20.29M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 11.0% higher than the 18.29M of fiscal 2024. The market data feed counts 20.00M shares outstanding today.

What is the growth rate of Ligand Pharmaceuticals's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 3.8% a year; over ten years the rate was −5.0% a year.

What are the highest and lowest diluted share count figures on record for Ligand Pharmaceuticals?

Across the 17 fiscal years on record (2009–2025), the highest was 38.58M in fiscal 2018 and the lowest 16.83M in fiscal 2020.

How is Ligand Pharmaceuticals's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Ligand Pharmaceuticals it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ligand Pharmaceuticals (LGND) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/LGND/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.